Sentinel node biopsy in breast cancer.

[1]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[2]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[3]  A C Johnson,et al.  Gamma-probe-guided resection of the sentinel lymph node in breast cancer. , 1998, The American surgeon.

[4]  P. Stanton,et al.  Sentinel node localization in patients with breast cancer , 1998, The British journal of surgery.

[5]  M. Papa,et al.  Sentinel lymph node involvement--a predictor for axillary node status with breast cancer--has the time come? , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  A. Giuliano,et al.  Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. , 1998, Archives of surgery.

[7]  R. Elashoff,et al.  Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran , 1998, Cancer.

[8]  T. Yeatman,et al.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. , 1998, Annals of surgery.

[9]  H. Cody,et al.  Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. , 1998, Journal of the American College of Surgeons.

[10]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[11]  P S Dale,et al.  Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. , 1998, The American surgeon.

[12]  J. Guenther,et al.  Sentinel lymphadenectomy for breast cancer in a community managed care setting. , 1997, The cancer journal from Scientific American.

[13]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[14]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[15]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. V. van Diest,et al.  Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[18]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[19]  C. O'brien,et al.  Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes , 1995, Melanoma research.

[20]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[21]  S. Ménard,et al.  Prognosis based on primary breast carcinoma instead of pathological nodal status. , 1994, British Journal of Cancer.

[22]  Alice Chung,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[23]  L. Karnell,et al.  The national cancer data base report on breast cancer , 1994, Cancer.

[24]  M. Silverstein,et al.  Axillary lymph node dissection for t1a breast carcinoma. Is it indicated? , 1994, Cancer.

[25]  E. McDermott,et al.  Audit of complete axillary dissection in early breast cancer. , 1994, European journal of cancer.

[26]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[27]  S. Michalas,et al.  Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. , 1993, Oncology.

[28]  C. Perez,et al.  Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[29]  G. Hortobagyi,et al.  Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer , 1993, Cancer.

[30]  M. Noguchi,et al.  Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases. , 1993, British Journal of Cancer.

[31]  J. Tjandra,et al.  Detection and significance of occult metastases in node‐negative breast cancer , 1993, The British journal of surgery.

[32]  M. Noguchi,et al.  Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer. , 1993, Surgical oncology.

[33]  J. Coindre,et al.  Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. , 1992, British Journal of Cancer.

[34]  I Taylor,et al.  Assessment of morbidity from complete axillary dissection. , 1992, British Journal of Cancer.

[35]  B. Asselain,et al.  Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer , 1992, The Lancet.

[36]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[37]  J. Thomas,et al.  Radical axillary dissection in the staging and treatment of breast cancer. , 1992, Annals of the Royal College of Surgeons of England.

[38]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[39]  A. D. Schryver,et al.  Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women: 1 , 1992 .

[40]  A. Giuliano,et al.  Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology. , 1991, Disease markers.

[41]  E. Marussi,et al.  Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. , 1991, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[42]  F. Vicini,et al.  Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[44]  D. Schultz,et al.  Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. , 1989, International journal of radiation oncology, biology, physics.

[45]  D. Sedmak,et al.  Prognostic significance of cytokeratin-positive breast cancer metastases. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[46]  P. C. Jolly,et al.  Factors affecting the incidence of lymph node metastases in small cancers of the breast. , 1989, American journal of surgery.

[47]  M. Pamilo,et al.  Real‐time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[48]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[49]  J. Coindre,et al.  Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. , 1987, British Journal of Cancer.

[50]  A. Recht,et al.  Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. , 1986, International journal of radiation oncology, biology, physics.

[51]  D. Easton,et al.  Risk of lymphoedema following the treatment of breast cancer , 1986, The British journal of surgery.

[52]  Sacre Ra.  Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. , 1986 .

[53]  B. Fisher,et al.  Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure , 1984, Cancer.

[54]  P. Saigo,et al.  Axillary Micro- and Macrometastases in Breast Cancer: Prognostic Significance of Tumor Size , 1981, Annals of surgery.

[55]  C. Redmond,et al.  The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. , 1981, Surgery, gynecology & obstetrics.

[56]  J. Hayward,et al.  Assessment of Axillary Lymph Node Status , 1980, Annals of surgery.

[57]  H. Rockette,et al.  Detection and significance of occult axillary node metastases in patients with invasive breast cancer , 1978, Cancer.

[58]  R. Cabanas,et al.  An approach for the treatment of penile carcinoma , 1977, Cancer.

[59]  J. Pickren.  Significance of occult metastases. A study of breast cancer , 1961, Cancer.